Suppressive Effects of Various Amino Acids Against Ouabain-Induced Seizures in Rats

Total Page:16

File Type:pdf, Size:1020Kb

Suppressive Effects of Various Amino Acids Against Ouabain-Induced Seizures in Rats THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES is Suppressive Effects of Various Amino Acids against Ouabain-Induced Seizures in Rats Y. TSUKADA, N. INOUE, J. DONALDSON, and A. BARBEAU SUMMARY: The suppressive effect of thionic acid showed increases in inci­ INTRODUCTION various amino acids against ouabain- dence of running and leaping seizures induced seizures was investigated in while L-arginine in high concentrations Recent investigations on the young female rats. The amino acids caused aggravation in clonic-tonic biochemistry of convulsive seizures were injected into the left lateral ven­ seizures. L-cysteine, even in low concen­ have revealed the existence of ab­ tricle 10 minutes prior to the intra­ trations, also brought about an increase normalities in the metabolism or ventricular administration of 5 jj.g. of in the occurrence and incidence of brain content of various amino ouabain. Animals receiving 1.9 x 10A M clonic-tonic seizures. The ED^of hypo­ acids. For example, an accumulation solutions of hypotaurine and of fir taurine was 10.11 x 10~2 M for running 3, of alanine and decreased citrate alanine were almost completely protected seizures and 4.63 x 10- M for clonic- levels were observed in the precon­ from the ouabain seizures. Administra­ tonic seizures; that of fi -alanine was tion of L-alanine and of glycine was also 14.01 x 10~2 M for running seizures and vulsive stage; on the other hand, effective, although running and leaping 5.50 x 10-2 M for clonic-tonic seizures. GABA increased in rat brain during seizures still occurred to some extent. However, hypotaurine and fi-alanine, tonic seizures as well as during Betaine reduced only clonic-tonic and the most effective compounds tested in post-convulsive stages (Nahorski et whole body flexion and extension the present studies, provided less protec­ al, 1970). According to some au­ seizures. In contrast, L-proline exclu­ tion than taurine previously examined thors, electroconvulsive shocks sively suppressed clonic-tonic and focal by us under similar conditions (Izumi markedly inhibit the conversion of clonic seizures. Rats injected with ise- et al., 1973). 14C-glucose to amino acids and the incorporation of 14C into pro­ teins in mouse brain (Dunn and RESUME: Nous avons etudie I'effet ayant regu I'acide isethionique mont- Giudetta, 1971) and in rat neo- suppresseur de plusieurs acides amines rerent une augmentation de Yincidence cortical slices (Jones and Mcllwain, contre les convulsions induites par la des convulsions cursives et des sauts. 1971). These findings were chal­ ouabaine chez lajeune rate. Les acides La L-arginine, en forte concentration, lenged by others (Barkulis et al., amines furent injectes dans le ventricule aggravait les convulsion tonico- 1960; Orrego and Lipmann, 1967). lateral gauche 10 minutes avant Vad­ cloniques. II enfut egalement ainsi pour ministration intraventriculaire de 5/j.g. la L-cysteine, meme en faibles concen­ Recently, van Gelder et al. (1972) de ouabaine. Les animaux recevant des trations. La DEgo de I'hypotaurine est reported lower levels of GABA and solutions de concentration 1.9 x 10-1 M de 10.11 x 10~2 M pour les convulsions aspartic acid in all regions of epilep­ d'hypotaurine et de fi -alanine etaient cursives et de 4.63 x 10-2 M pour les tic human cortex sampled and lower presque completement proteges contre convulsions tonico-cloniques; celles de concentrations of glutamic acid and les convulsions induites. L'administra­ la fi-alanine sont de 14.01 x 10-2 M et taurine together with very high tion de L-alanine et de glycine etait de 5.50 x 10-2 M, respectivement. Ce- glycine levels in human cortical egalement efficace, meme si les de- pendant il faut noter que Yhypotaurine epileptic foci. Koyama (1972) ob­ charges cursives et les sauts etaient et la fi -alanine, les composes les plus served similar decreased concentra­ encore presents. La betaine ne reduisait efficaces dans la presente etude, offrent tions of taurine, glutamate, asparate que les convulsions tonico-cloniques ou tous deux une protection moindre contre celles se manifestant par une flexion et les convulsions induites par la ouabaine and GABA during the period pre­ une extension du corps. Par contraste, que la taurine que nous avions pre- ceding cobalt induced convulsions la L-proline supprimait exclusivement alablement etudie en detail (Izumi et al., in cats. However, Reynolds and Gal­ les convulsions tonico-cloniques oupure- 1973). lagher (1973) found neither changes ment cloniques localisees. Les rates in amino acid levels nor alterations of U-14C-glucose incorporation into amino acids during any of the stages of the seizure induced by Flurothyl. Department of Neurobiology, Clinical Research Some amino acids have been Institute of Montreal, 110 Pine Avenue West, shown to be neurotransmitter candi­ Montreal, Quebec, Canada. dates with inhibitory or excitatory Reprint address: Dr. Andre Barbeau, Clinical Research Institute of Montreal, 110 Pine Avenue functions. Micro-electrophoretic West, Montreal, Quebec, Canada H2W 1R7. techniques to substantiate this 214 - NOVEMBER 1974 Downloaded from https://www.cambridge.org/core. IP address: 170.106.33.14, on 30 Sep 2021 at 00:59:18, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S031716710001979X # LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES nypothesis were reviewed by Curtis administration of amino acid and sons of seizure incidence and of la­ and Crawford (1969). Uptake studies ouabain solutions which were in­ tency in onset of the first seizure. have been carried out in central jected through the cannula at a rate nervous system tissue or retina (Bal- of 25nl./min. Two different doses of RESULTS car and Johnston, 1973; Ehinger, each amino acid (9.5 x 10-2 M or 1.9 J Occurrence and incidence 1972; Kaczmarek and Davison, x 10 M) were administered 10 mi­ Pretreatment of the animals with 1972; Snyder, Young et al., 1973; nutes prior to the injection of 5^g. in hypotaurine (the main precursor of Snyder, Yamamura et al., 1973). 50 p.1. ouabain. Moreover, various taurine), /3-alanine, L-alanine and Finally, some authors have ap­ concentrations of hypotaurine and glycine caused a dose dependent de­ proached the problem with the help j3-alanine were used to investigate crease in seizure occurrence and in­ of autoradiography (Ehinger and median effective doses (ED50) for cidence (Tables 1 and 2). Test rats Falek, 1971; Iversen and Schon, running and clonic-tonic seizures. receiving hypotaurine at 10 minutes 1973). These investigations con­ The control animals received an in­ prior to the ouabain injection were cluded that 7-aminobutyric acid jection volume of 50 1. of buffered kept free from all seizure activities at (GABA), glycine, 0 -alanine and saline. The effects of amino acids high concentrations (1.9 x 10-1 M). taurine may be inhibitory neuro­ against the different types of Moreover, even in low concentra­ transmitters, while glutamic acid and ouabain-induced seizures previously tions (9.5 x 10-2 M), the compound aspartic acid have excitatory func­ described in rats (Izumi et al., 1973) completely suppressed clonic-tonic, tions. were observed for fifteen minutes whole body flexion and extension after the administration of ouabain. On the other hand, once recom­ seizures (WBFE), and to a lesser mended trials of treatment with Preparation of solutions extent, focal clonic seizures. This amino acids in human epilepsy no Ouabain solutions were prepared concentration of hypotaurine also longer appear useful today, except at a concentration of 5ju,g./50/il. in decreased the incidence of running possibly with gamma-amino-beta- warm 0.85% saline. The amino acids and leaping seizures. hydroxybutyric acid (GABOB) were dissolved in a NaCl solution Intraventricular administration of (Hahashi, 1972). Recently, however, containing 5 mM phosphate buffer, 1.9 x 10*1 Mf3 -alanine showed sig­ some antiseizure effects of taurine to obtain an osmotic pressure of 290 nificant protective effects against all have been reported (Barbeau and to 300 mosm. and the solutions were types of ouabain-induced seizures. Donaldson, 1974; Izumi et al, 1973; checked by osmometry. The pH of At low concentrations (9.5 x 10-2 M) van Gelder, 1972). van Gelder (1972) the amino acid solutions was ad­ the compound completely abolished first demonstrated the suppressive justed to 7.0-7.2. The control solu­ focal clonic and WBFE seizures and effect of taurine administered sys- tion contained 5mM. phosphate buf­ significantly decreased clonic-tonic temically against cobalt-induced fer in a NaCl solution. seizures. seizures in cat and mouse. Izumi et al. (1973) then found that the in­ Ouabain, betaine and isethionic Animals injected with high con­ traventricular injection of taurine acid were purchased from Sigma centrations of either L-alanine or revealed more marked antiseizure Chemical Co., glycine, L-alanine glycine were protected from WBFE, effects than GABA against ouabain- and L-arginine from California clonic-tonic and focal clonic seizures induced seizures in rats. Moreover, Biochemical Research, hypotaurine and to a lesser extent from running Barbeau and Donaldson (1974) re­ and L-cysteine from Calbiochem, and leaping seizures. Low concen­ ported that taurine also possessed L-proline from Nutritional Biochem­ trations of these two amino acids also anticonvulsant activity against cer­ ical Corporation and /3-alanine from completely suppressed WBFE and tain types of human epilepsy. Eastman Kodak Co. clonic-tonic seizures. Furthermore, glycine had some suppressive effect The present studies were carried STATISTICS against leaping and running seizures out to investigate the activity against at a low concentration. Administra­ Median effective doses (EDso ± 2 1 ouabain-induced seizures in rats of 95% confidence limits) of tion of 9.5 x 10- M or 1.9 x 10- M various amino acids, including some hypotaurine and /3 -alanine against betaine protected rats from WBFE precursors, a metabolite and various clonic-tonic and running seizures and clonic-tonic seizures only.
Recommended publications
  • Oxidative Stress and Inflammation in Hepatic Diseases
    Review Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine Kívia Queiroz de Andrade 1, Fabiana Andréa Moura 1,2, John Marques dos Santos 3, Orlando Roberto Pimentel de Araújo 3, Juliana Célia de Farias Santos 2 and Marília Oliveira Fonseca Goulart 3,* Received: 10 October 2015; Accepted: 4 December 2015; Published: 18 December 2015 Academic Editor: Guido Haenen 1 Pós Graduação em Ciências da Saúde (PPGCS), Campus A. C. Simões, Tabuleiro dos Martins, 57072-970 Maceió, AL, Brazil; [email protected] (K.Q.A.); [email protected] (F.A.M.) 2 Faculdade de Nutrição/Universidade Federal de Alagoas (FANUT/UFAL), Campus A. C. Simões, Tabuleiro dos Martins, 57072-970 Maceió, AL, Brazil; [email protected] 3 Instituto de Química e Biotecnologia (IQB), Universidade Federal de Alagoas (UFAL), Campus A. C. Simões, Tabuleiro dos Martins, 57072-970 Maceió, AL, Brazil; [email protected] (J.M.S.); [email protected] (O.R.P.A.) * Correspondence: [email protected]; Tel.: +55-82-98818-0463 Abstract: Liver disease is highly prevalent in the world. Oxidative stress (OS) and inflammation are the most important pathogenetic events in liver diseases, regardless the different etiology and natural course. N-acetyl-L-cysteine (the active form) (NAC) is being studied in diseases characterized by increased OS or decreased glutathione (GSH) level. NAC acts mainly on the supply of cysteine for GSH synthesis. The objective of this review is to examine experimental and clinical studies that evaluate the antioxidant and anti-inflammatory roles of NAC in attenuating markers of inflammation and OS in hepatic damage.
    [Show full text]
  • Identification of a Distinct Metabolomic Subtype of Sporadic ALS Patients
    bioRxiv preprint doi: https://doi.org/10.1101/416396; this version posted September 13, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of a Distinct Metabolomic Subtype of Sporadic ALS Patients Running title – Increased cysteine and glucose metabolism in sALS cases Qiuying Chen, PhD1*, Davinder Sandhu, M.S.1*, Csaba Konrad, PhD2, Dipa Roychoudhury, PhD3, Benjamin I. Schwartz1, Roger R. Cheng1, Kirsten Bredvik2, Hibiki Kawamata, PhD2, Elizabeth L. Calder, PhD4, Lorenz Studer, MD4, Steven. M. Fischer3, Giovanni Manfredi MD/PhD2* and Steven. S. Gross, PhD1* *Joint first/senior authors 1Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA 2Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA 3Agilent Technology, Santa Clara, CA, USA 4The Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Center, New York, NY. Keywords: sporadic amyotrophic lateral sclerosis, metabolomics, stable isotope tracing, trans-sulfuration, hypermetabolism, disease stratification, energy metabolism Co-Corresponding Authors: Steven S. Gross, PhD Department of Pharmacology Weill Cornell Medicine Phone: 212-746-6257 Email: [email protected] Giovanni Manfredi, MD/PhD Brain and Mind Research Institute Weill Cornell Medicine Phone: 646-962-8172 Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/416396; this version posted September 13, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Number of characters: Title --- 94 Running head---48 Number of words: Title --- 13 Running head --- 8 Abstract---232 Introduction --- 549 Discussion --- 1126 Body of manuscript --- 5706 Number of figures: 8 Number of color figures: 8 Number of tables:1 2 bioRxiv preprint doi: https://doi.org/10.1101/416396; this version posted September 13, 2018.
    [Show full text]
  • Supplemental Table 1. Differences in Fasting Metabolites (All) by CKD Status in Plasma
    Supplemental table 1. Differences in fasting metabolites (all) by CKD status in plasma. Metabolites in bold show hits controlling FDR at 10%, in a model that controls for age, sex, race (white versus not), and weight. Ordered by subclasses of metabolites followed by adjusted percent difference between CKD and controls and adjusted p-value for difference. Metabolite % Difference p-value q-value Pathway in CKD, compared with controls Cystine (241.1 / 120.0) 33 2.60E-09 1.52E-08 Amino Acid Proline (116.1 / 70.0) 20 0.000195 0.000692 Amino Acid 2-Hydroxyisovaleric Acid (117.0 / 71.0) 47 0.000331 0.001139 Amino Acid Tyrosine (182.1 / 136.0) -13 0.000633 0.002014 Amino Acid Serine (106.0 / 60.0) -8 0.029507 0.065132 Amino Acid Glycine (76.0 / 30.1) 13 0.032003 0.06842 Amino Acid Leucine (132.1 / 86.0) -5 0.067499 0.139499 Amino Acid 5-Aminovaleric Acid (118.0 / 55.0) -4 0.127339 0.253324 Amino Acid Threonine (120.1 / 74.0 (2)) -7 0.145125 0.281179 Amino Acid Glutamine (147.1 / 84.0) 3 0.169291 0.318061 Amino Acid Valine (118.1 / 72.0) -4 0.201091 0.36138 Amino Acid Arginine (175.1 / 70.0) 5 0.209045 0.362752 Amino Acid Sarcosine (89.9 / 44.0) -7 0.209395 0.362752 Amino Acid Cadaverine (103.0 / 86.0) 4 0.281896 0.459935 Amino Acid Histidine (156.1 / 110.0) 3 0.319987 0.495386 Amino Acid Alanine (90.0 / 44.0) 5 0.330111 0.499193 Amino Acid iso-Leucine (132.1 / 86.0 (2)) -3 0.336431 0.50262 Amino Acid Phenylalanine (166.1 / 120.0) 2 0.461445 0.61526 Amino Acid Methionine (150.1 / 61.0) -3 0.516557 0.681415 Amino Acid Pipecolate (130.0 / 84.0) -2
    [Show full text]
  • Taurine Supplementation Improves the Utilization of Sulfur
    Available online at www.sciencedirect.com Journal of Nutritional Biochemistry 20 (2009) 132–139 Taurine supplementation improves the utilization of sulfur-containing amino acids in rats continually administrated alcohol Hui-Ting Yanga, Yi-Wen Chienb, Jen-Horng Tsenc, Ching-Chien Changb,d, ⁎ ⁎ Jer-Hwa Change, ,1, Shih-Yi Huangb, ,1 aSchool of Pharmaceutical Science, Taipei Medical University, Taipei bSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei cSchool of Nutrition, China Medical University, Taichung, Taiwan dGeneral Education Center, Northern Taiwan Institute of Science and Technology, Taipei eDepartment of Internal Medicine, Taipei Medical University Wan Fang Hospital, Taipei, Taiwan Received 27 September 2007; received in revised form 18 December 2007; accepted 4 January 2008 Abstract The main purpose of this study was to evaluate changes in brain sulfur-containing amino acid (SCAA) metabolism to determine whether taurine intervened under continuous alcohol intake. We fed 80 male Sprague–Dawley rats 30% alcohol-containing water for 4 weeks. Eighty animals were divided into two groups (with or without 2 g/kg body weight taurine supplementation), and five were killed every week in each group for monitoring SCAA changes in the brain, liver, kidneys and heart. Results indicated that the plasma alcohol concentration increased from Weeks 1–4; however, animals with taurine supplementation showed a lower plasma concentration of ethanol in Week 2. As to SCAA concentrations, cysteine and taurine were both lower after a week of alcohol ingestion in the brain and plasma; the same declining trend was shown in the liver in Week 2. In contrast, plasma and hepatic concentrations of homocysteine were elevated in Week 2, and the plasma S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio also decreased in Week 1.
    [Show full text]
  • Combined Metabolic Activators Improve Cognitive Functions Without Altering Motor
    medRxiv preprint doi: https://doi.org/10.1101/2021.07.28.21261293; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Combined Metabolic Activators Improve Cognitive Functions without Altering Motor Scores in Parkinson’s Disease Burak Yulug1,#, Ozlem Altay2,#, Xiangyu Li2, #, Lutfu Hanoglu3, Seyda Cankaya1, Simon Lam4, Hong Yang2, Ebru Coskun3, Ezgi İdil1, Rahim Nogaylar1, Ahmet Hacımuftuoglu5, Muhammad Arif2, Saeed Shoaie2,4, Cheng Zhang2.6, Jens Nielsen7, Hasan Turkez8, Jan Borén9, Mathias Uhlén2,*, Adil Mardinoglu2,4,* 1Department of Neurology and Neuroscience, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey 2Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden 3Department of Neurology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey 4Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, United Kingdom 5Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey. 6School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China 7Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden 8Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey 9Department
    [Show full text]
  • The Biosynthesis Reaction of Hypotaurine to Taurine
    UNIVERSITY OF CENTRAL OKLAHOMA Edmond, Oklahoma Jackson College of Graduate Studies The Biosynthesis Reaction of Hypotaurine to Taurine A THESIS SUBMITTED TO THE GRADUATE FACULTY In partial fulfillment of the requirements For the degree of MASTER OF SCIENCE IN BIOLOGY By Roxanna Q. Grove Edmond, Oklahoma 2018 Acknowledgments Working on this project has been a period of intense learning for me, not only in the scientific arena, but also on a personal level. Writing this thesis has had a significant impact on me. I would like to reflect on people who have been supported and helped me so much throughout this period. First of all, I would like to express my gratitude toward my advisor, Dr. Steven J. Karpowicz, for his devotion, inspiration, and guidance. I am so grateful to have the opportunity to work with such an intelligent, dedicated, and patient professor. I appreciate his vast knowledge and skills in many areas such as biochemistry, genetics, and bioinformatics, and his assistance in writing this thesis. I would like to thank the other members of my committee, Dr. Nikki Seagraves, Dr. Hari Kotturi, and Dr. Lilian Chooback, for their guidance, support, and for providing materials throughout this project. An exceptional thanks go to Dr. John Bowen of the Department of Chemistry for advice in the analytical laboratory and Dr. Susan L. Nimmo from the Department of Chemistry and Biochemistry at the University of Oklahoma for assistance with NMR. This project was supported by funding from the College of Mathematics and Science and a Research, Creative, and Scholarly Activities (RCSA) grant from the Office of High Impact Practices at UCO.
    [Show full text]
  • Cysteamine: an Old Drug with New Potential
    Drug Discovery Today Volume 18, Numbers 15/16 August 2013 REVIEWS POST SCREEN Cysteamine: an old drug with new potential Reviews 1,2 3 1,2,4 Martine Besouw , Rosalinde Masereeuw , Lambert van den Heuvel and 1,2 Elena Levtchenko 1 Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium 2 Laboratory of Pediatrics, Department of Development & Regeneration, Catholic University Leuven, Belgium 3 Department of Pharmacology and Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands 4 Laboratory for Genetic, Endocrine and Metabolic Disorders, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Cysteamine is an amino thiol with the chemical formula HSCH2CH2NH2. Endogenously, cysteamine is derived from coenzyme A degradation, although its plasma concentrations are low. Most experience with cysteamine as a drug originates from the field of the orphan disease cystinosis, in which cysteamine is prescribed to decrease intralysosomal cystine accumulation. However, over the years, the drug has been used for several other applications both in vitro and in vivo. In this article, we review the different applications of cysteamine, ending with an overview of ongoing clinical trials for new indications, such as neurodegenerative disorders and nonalcoholic fatty liver disease (NAFLD). The recent development of an enteric-coated cysteamine formulation makes cysteamine more patient friendly and will extend its applicability for both old and new indications. Endogenous cysteamine production cysteine, it is oxidized into taurine by hypotaurine dehydrogenase Cysteamine (synonyms: b-mercaptoethylamine, 2-aminoetha- (Fig. 1b). Taurine is excreted either in urine, or in feces in the form nethiol, 2-mercaptoethylamine, decarboxycysteine, thioethano- of bile salts [3].
    [Show full text]
  • Omics in Myopia
    Journal of Clinical Medicine Review Omics in Myopia Emil Tomasz Grochowski 1,* , Karolina Pietrowska 2 , Tomasz Kowalczyk 2, Zofia Mariak 1, Adam Kretowski 2,3, Michal Ciborowski 2,* and Diana Anna Dmuchowska 1,* 1 Department of Ophthalmology, Medical University of Bialystok, M. Sklodowskiej Curie 24a, 15-276 Bialystok, Poland; [email protected] 2 Clinical Research Centre, Medical University of Bialystok, M. Sklodowskiej Curie 24a, 15-276 Bialystok, Poland; [email protected] (K.P.); [email protected] (T.K.); [email protected] (A.K.) 3 Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M. Sklodowskiej Curie 24a, 15-276 Bialystok, Poland * Correspondence: [email protected] (E.T.G.); [email protected] (M.C.); [email protected] (D.A.D.) Received: 8 October 2020; Accepted: 25 October 2020; Published: 28 October 2020 Abstract: Myopia is a globally emerging issue, with multiple medical and socio-economic burdens and no well-established causal treatment thus far. A better insight into altered biochemical pathways and underlying pathogenesis might facilitate early diagnosis and treatment of myopia, ultimately leading to the development of more effective preventive and therapeutic measures. In this review, we summarize current data about the metabolomics and proteomics of myopia in humans and present various experimental approaches and animal models, along with their strengths and weaknesses. We also discuss the potential applicability of these
    [Show full text]
  • Exogenous Potassium
    plants Article Exogenous Potassium (K+) Positively Regulates Na+/H+ Antiport System, Carbohydrate Metabolism, and Ascorbate–Glutathione Cycle in H2S-Dependent Manner in NaCl-Stressed Tomato Seedling Roots M. Nasir Khan 1,*, Soumya Mukherjee 2 , Asma A. Al-Huqail 3, Riyadh A. Basahi 1, Hayssam M. Ali 3 , Bander M. A. Al-Munqedhi 3, Manzer H. Siddiqui 3,* and Hazem M. Kalaji 4 1 Department of Biology, Faculty of Science, College of Haql, University of Tabuk, Tabuk 71491, Saudi Arabia; [email protected] 2 Department of Botany, Jangipur College, University of Kalyani, West Bengal 742213, India; [email protected] 3 Chair of Climate Change, Environmental Development and Vegetation Cover, Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; [email protected] (A.A.A.-H.); [email protected] (H.M.A.); [email protected] (B.M.A.A.-M.) 4 Department of Plant Physiology, Institute of Biology, Warsaw University of Life Sciences SGGW, 159 Nowoursynowska 159, 02-776 Warsaw, Poland; [email protected] * Correspondence: [email protected] (M.N.K.); [email protected] (M.H.S.) Citation: Khan, M.N.; Mukherjee, S.; Al-Huqail, A.A.; Basahi, R.A.; Ali, Abstract: Potassium (K+) is one of the vital macronutrients required by plants for proper growth H.M.; Al-Munqedhi, B.M.A.; and blossoming harvest. In addition, K+ also plays a decisive role in promoting tolerance to various Siddiqui, M.H.; Kalaji, H.M. Exogenous Potassium (K+) Positively stresses. Under stressful conditions, plants deploy their defense system through various signaling Regulates Na+/H+ Antiport System, molecules, including hydrogen sulfide (H2S).
    [Show full text]
  • Temporal Resolution and Determination of the Mechanism of Ethanol-Induced Taurine Efflux
    TEMPORAL RESOLUTION AND DETERMINATION OF THE MECHANISM OF ETHANOL-INDUCED TAURINE EFFLUX By ANTHONY DONALD SMITH A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF FLORIDA 2005 Copyright 2005 by Anthony Donald Smith ACKNOWLEDGMENTS The first person I would like to thank would be Dr. Joanna Peris. Her scientific wisdom, unique perspective on life and enjoyable demeanor has made this journey a very smooth one. She has exposed me to many very interesting ideas and people and I simply cannot thank her enough. I would like to thank my supervisory committee for their ideas, suggestions and (occasionally) lab equipment: Drs. Michael King, William Millard, Michael Meldrum and Maureen Keller-Wood. I would also like to thank Dr. Robert Kennedy and his lab for all their help, materials and lab space at the University of Michigan. I would also like to thank Dr. Bärbel Eppler for help/advice throughout the years. I would like to thank the late Dr. Ralph Dawson. He was a great scientist and an expert in the taurine field and I appreciated his input into my experiments. He was the first to congratulate me when I passed my qualifiers and I regret that he is not here to congratulate me now. His advice and expertise will be greatly missed as well as his wit. Most importantly I thank my parents for all of their love and support. iii TABLE OF CONTENTS page ACKNOWLEDGMENTS ................................................................................................. iii LIST OF FIGURES ......................................................................................................... viii ABSTRACT......................................................................................................................
    [Show full text]
  • Oxidative Stress in an Assisted Reproductive Techniques Setting
    MODERN TRENDS Edward E. Wallach, M.D. Associate Editor Oxidative stress in an assisted reproductive techniques setting Ashok Agarwal, Ph.D.,a Tamer M. Said, M.D.,a Mohamed A. Bedaiwy, M.D.,b Jashoman Banerjee, M.D.,a and Juan G. Alvarez, M.D., Ph.D.c a Center for Advanced Research in Human Reproduction, Infertility and Sexual Function, Glickman Urological Institute and Department of Obstetrics-Gynecology, Cleveland Clinic Foundation, Cleveland, Ohio; b Mount Sinai Hospital, Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada; and c Centro de Infertilidad Masculina ANDROGEN, La Coruña, Spain, and Harvard Medical School, Boston, Massachusetts Objective: The manipulation of gametes and embryos in an in vitro environment when performing assisted reproductive techniques (ART) carries the risk of exposure of these cells to supraphysiological levels of reactive oxygen species (ROS). The main objective of this review is to provide ART personnel with all the necessary information regarding the development of oxidative stress in an ART setting, as well as the sources of ROS and the mechanisms of oxidative stress–induced damage during ART procedures. The impact of oxidative stress on ART outcome and the different strategies designed to prevent it are also discussed. Design: Review of international scientific literature. A question-and-answer format was adopted in an attempt to convey comprehensive information in a simple yet focused manner. Result(s): The pO2 to which gametes and the embryo are normally exposed in vivo is significantly lower than in vitro. This results in increased production of ROS. Increase in levels of ROS without a concomitant rise in antioxidant defenses leads to oxidative stress.
    [Show full text]
  • Taurine and Osmoregulation. IV. Cerebral Taurine Transport Is Increased in Rats with Hypernatremic Dehydration1
    003 1-3998/92/3201-0118$03.00/0 PEDIATRIC RESEARCH Vol. 32, No. 1, 1992 Copyright O 1992 International Pediatric Research Foundation, Inc. Printed in U.S.A. Taurine and Osmoregulation. IV. Cerebral Taurine Transport Is Increased in Rats with Hypernatremic Dehydration1 HOWARD TRACHTMAN, STEPHEN FUTTERWEIT, AND RICHARD DEL PIZZO Department of Pediatrics, Schneider Children's Hospital, Long Island Jewish Medical Center, Long Island Campus for Albert Einstein College of Medicine, New Hyde Park, New York 11042 ABSTRACT. Taurine is an organic osmolyte in brain cells. Regulation of cerebral cell volume in the face of osmolal stress We studied whether cerebral taurine transport is enhanced is an important biological function in all species (1). In terrestrial as part of the cell volume regulatory adaptation to hyper- mammals, the brain is encased in a rigid, bony vault. Therefore, natremia. Hypernatremic dehydration was induced for 48 this organ poorly tolerates sudden changes in cell size induced h. Synaptosomes, metabolically active nerve terminal ves- by changes in serum osmolality (2). Cerebral cells have developed icles, were isolated by homogenization of brain and purifi- the capacity to modulate the intracellular content of osmopro- cation on a discontinuous Ficoll gradient. Taurine transport tective molecules in response to hypo- and hyperosmolal states was evaluated in vitro using a rapid filtration assay. After and to minimize fluctuations in cell size (3). The important 48 h of hypernatremia, there was a 22.4% increment in classes of compatible, organic osmolytes include inorganic ions, Na+-specific taurine transport from 2.99 f 0.16 to 3.66 2 amino acids, polyhydric sugar alcohols, and methylamines (4).
    [Show full text]